FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency…
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket. The post FDA Approval Makes Rocket Pharma Gene Therapy…
How Are Health Systems Assessing ROI for AI Tools?
Michael Meucci, CEO of health data platform Arcadia, thinks health systems are changing their thinking about ROI when it comes to AI projects. As providers face tighter budgets, he said they’re broadening how they measure AI’s ROI, including benefits like reducing clinician burnout. The post How Are Health Systems Assessing ROI for AI Tools? appeared…
Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust
AI in healthcare will not fail because the models are weak. It will stall when leaders hesitate to redesign how decisions are made, measured and governed. The post Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust appeared first on MedCity News.
The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity
Providers that embrace benchmarks from outside of healthcare and move toward improved non-clinical spend management will unlock the resilience, innovation, and possibilities needed to stay strong in the years ahead. The post The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity appeared first on MedCity News.
AI Can Expand Access to Healthcare — But Only With Human Action
Health systems can turn insights into action, ensuring that preventive care actually happens by combining accurate risk prediction with human outreach and careful planning. The post AI Can Expand Access to Healthcare — But Only With Human Action appeared first on MedCity News.
HIV Symptoms in Women Early Signs Causes Testing Prevention
HIV Symptoms in Women: Early Warning Signs, Causes, Testing, and Prevention Table of Contents National Women and Girls HIV/AIDS Awareness Day National Women and Girls HIV/AIDS Awareness Day takes place on March 10. The main goal of the day is to raise awareness about HIV symptoms in women, highlight the significance of HIV testing, and…
drug and alcohol abuse ,health risks,facts,prevention tips
The post drug and alcohol abuse ,health risks,facts,prevention tips appeared first on Medifyhome.
kidney disease symptoms early diagnosis tests prevention
The post kidney disease symptoms early diagnosis tests prevention appeared first on Medifyhome.
Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology
Alumis’s genomic research guided its development of envudeucitinib, a TYK2 inhibitor that some analysts now view as best in class. The Phase 3 results that will support a planned FDA submission in plaque psoriasis are scheduled for presentation this weekend during the American Academy of Dermatology annual meeting in Denver. The post Taking a Page…
UnitedHealthcare Unveils AI Companion to Improve Navigation
UnitedHealthcare launched Avery, an AI assistant to help members manage benefits and care with live support backup. The post UnitedHealthcare Unveils AI Companion to Improve Navigation appeared first on MedCity News.
